Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Delivery of Anticancer Drugs"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 10 September 2023 | Viewed by 1833
Special Issue Editor
Interests: drug discovery; pro-drugs; drug conjugates; anti-cancer drugs; antimicrobial peptides; organic synthesis; natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
We are pleased to announce the launch of a new Special Issue of Pharmaceutics entitled “Delivery of Anticancer Drugs”.
Despite many recent advances in both small-molecule and biological therapies, there persists the challenge of maintaining drug efficacy by ensuring that the drug reaches the tumor target.
Delivery of anticancer drugs selectively and effectively to the tumor site can be challenging for a number of reasons, including the tumor microenvironment, poor localized vasculature, and barriers to drug penetration, such as the location of the tumor, cellular drug efflux mechanisms, or dense stromal tissue layers.
The Special Issue aims to highlight the latest pharmaceutical research in developing methods for effective delivery of anticancer drugs to tumors, including approaches such as drug conjugates, polymeric or biological carriers, nanoparticles, and tumor-selective prodrugs.
Dr. Sharon Rossiter
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer targets
- drug delivery
- drug conjugates
- drug targeting
- drug delivery